• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

NCCS Starburst 250px

What Caught Our Eye: A New GOP Health Plan, Looming Uncertainty for Insurers, Sharing Genetic Cancer Risks with Children, and More

April 21, 2017/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Health Care Coverage NCCS News /by actualize
What Caught Our Eye (WCOE), April 21, 2017
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

In the Spotlight

Trumpcare is back. And worse than ever.

Via Vox.com — “House Republicans are floating a new amendment to their health care bill — one that would likely cause even more Americans to lose coverage than the last version.

“Leaders of the staunchly conservative Freedom Caucus and the more moderate Tuesday Group have reportedly hashed out a proposal that would let some states ditch key Obamacare policies, such as the requirement to charge sick people the same for coverage as healthy people. States would also have the choice to opt out of the Affordable Care Act’s essential health benefit requirement.”

House GOP members are floating a new health plan. Here’s what’s in it. https://t.co/9R3uWsbp8F

— Vox (@voxdotcom) April 20, 2017


Affordable Care Act

“Bare Market: What Happens if Places Have No Obamacare Insurers?”

What would happen if all the Obamacare insurers left a given market? We may soon find out. https://t.co/QnS7wNfJu3 pic.twitter.com/5eWZfaImDE

— The Upshot (@UpshotNYT) April 19, 2017

Via New York Times Well Blog — “If all the insurers start leaving [the market], consumers there will find their options dwindling, and then their subsidies will become worthless. Most would end up uninsured. The problem could affect a substantial fraction of the approximately 11 million people currently enrolled in Obamacare coverage..”


“Health Insurers Asked Trump Administration for Reassurance on Obamacare. They Didn’t Get It.”

Health insurers asked the Trump administration for reassurance on Obamacare. They didn’t get it. https://t.co/owtXt9Css3

— Post Economy (@PostEconomy) April 18, 2017

Via Washington Post Wonkblog — “Health insurance executives seeking certainty on the future of federal funds that help lower-income Americans with their out-of-pocket health-care costs got no commitment that they would be paid next year in an hour-long meeting with Seema Verma, administrator of the Centers for Medicare and Medicaid Services (CMS), according to two insurance industry officials with knowledge of the meeting.”


“Tom Price’s big test: Keep Obamacare afloat”

Tom Price's big test: Keep Obamacare afloat https://t.co/FgoPhW6ODT

— POLITICO Pulse (@POLITICOPulse) April 19, 2017

Via Politico — “President Donald Trump doubles down on his repeal rhetoric, insurers are still awaiting key Obamacare funding and new disclosures highlight two lawmakers who are raking in the health care cash. But first: Tennessee is ground zero for the urgent challenge facing HHS Secretary Tom Price.”


“White House Pressures GOP Leaders on Obamacare”

White House thinks vote will happen Wednesday. Hill Republicans are not in same hurry to rush a health care vote. https://t.co/y5rhh6bGNv

— Josh Dawsey (@jdawsey1) April 20, 2017

Via Politico — “The White House is pressuring House GOP leaders for another showdown vote on repealing Obamacare next week so it can notch a legislative win before President Donald Trump’s first 100 days in office. But while the outlines of a possible deal are starting to come together, it’s far from clear that House Republican leaders have found the sweet spot to pass their embattled alternative health plan.”


Cancer Policy

“FDA Approves Drug for Hodgkin Lymphoma”

The FDA has approved pembrolizumab (Keytruda®) for some adult and pediatric patients with classical Hodgkin lymphoma https://t.co/vNawsluRLr pic.twitter.com/uvGp6WRWG7

— National Cancer Institute (@theNCI) April 18, 2017

From the National Cancer Institute (NCI) — “On March 14, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda®) for the treatment of some patients with classical Hodgkin lymphoma (cHL). The drug is approved for the treatment of both adult and pediatric patients with refractory cHL, or patients whose disease has relapsed after three or more lines of therapy.”


Coping with Cancer

“When to Tell Daughters About a Genetic Breast Cancer Risk”

When to Tell Daughters About a Genetic Breast Cancer Risk https://t.co/aPkU4KyQA3

— NYTimes Well (@nytimeswell) April 20, 2017

Via New York Times Well Blog — “As genetic testing has given women and men a trove of information about their health and risk for disease, it has also created a new challenge for parents and medical experts: when to share information with children who may share a genetic risk.”


“Relationships and Metastatic Breast Cancer”

https://twitter.com/cancernews247/status/855124941204635648

Via KXLY — “Dealing with metastatic breast cancer can put additional stress on any relationship. But having supportive relationships can make a big difference in your day-to-day life and emotional health.”


More From “What Caught Our Eye” »

Follow us on Twitter: @CancerAdvocacy


Tags: affordable care act, FDA, genetic testing, lymphoma, Medicaid, repeal and replace, What Caught Our Eye
Share this entry
  • Share on Facebook
  • Share on Twitter
https://canceradvocacy.org/wp-content/uploads/2017/01/NCCS-Starburst-250px.png 250 250 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2017-04-21 15:00:262017-04-21 15:00:26What Caught Our Eye: A New GOP Health Plan, Looming Uncertainty for Insurers, Sharing Genetic Cancer Risks with Children, and More
You might also like
NCCS Starburst Thumbnail WCOE: Brookings Event Examines Cost and Value, the ACA, and Accounting Practices in Medical Billing
NCCS Starburst 250px Health Care Roundup: White House Proposes Health Care Cuts; NCI’s Sharpless to Head FDA; Care Planning; Patient Safety; More
NCCS Starburst Thumbnail WCOE: Patients’ Need to Be Advised, Confidence in Cost Communication, Compassion, and NCCS CEO Weighs in on CMS’ Oncology Care Model
Dome Thumbnail starburst NCCS Joins Colleagues in Submitting Comments to HHS Regarding Proposed Rule on Notice of Benefit and Payment Parameters for 2016
NCCS Starburst 250px Health Care Roundup: Drug Pricing in TV Ads; Even with Insurance, Serious Illness Can Mean Financial Distress; Fertility in Young Survivors; More
NCCS Starburst 250px Health Care Roundup: Gov’t Shutdown Affects FDA; Health Care Hearings; Insomnia & Cancer; “When Cancer Meets the Internet;” More
ImageDoctor and PatThumbnail WCOE: Paying Doctors to Talk About End-of-Life Care
Fotolia 23428619 S e1461260836640 NCCS Submits Comments to CMS, Stresses Importance of ACA and Outlines Steps to Strengthen Law

Latest News

Coronavirus feat

COVID-19 Vaccines and Cancer: A Conversation with Cancer Expert Otis Brawley, MD

March 1, 2021
The National Coalition for Cancer Survivorship (NCCS) hosted a conversation on February…
Read more
https://canceradvocacy.org/wp-content/uploads/2020/03/Coronavirus-feat.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-03-01 11:49:192021-03-02 16:15:47COVID-19 Vaccines and Cancer: A Conversation with Cancer Expert Otis Brawley, MD
Canceradvocacy org default image

National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster

February 24, 2021
NOTE: This press release was originally published on the National Quality Forum (NQF)…
Read more
https://canceradvocacy.org/wp-content/uploads/2019/10/Canceradvocacy-org-default-image.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-02-24 21:01:392021-02-24 21:01:39National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster
HHS Humphrey bldg 1200

NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

February 19, 2021
The National Coalition for Cancer Survivorship (NCCS) joined with the Cancer Leadership…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-02-19 15:06:392021-02-24 19:29:10NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

ACA Update | April 14, 2017: Town Hall Headlines, Cost-Sharing Subsidies, the... ProtectOurCare 1024px ProtectOurCare 1024px ACA Update | April 21, 2017: House GOP Readies a Revised Health Care Bill
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute